RDY
Dr. Reddy’s Laboratories Ltd ADR
NYSE: RDY · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$13.73
-2.14% today
Updated 2026-04-29
Market cap
$11.46B
P/E ratio
19.07
P/S ratio
0.03x
EPS (TTM)
$0.72
Dividend yield
0.67%
52W range
$13 – $16
Volume
2.4M
Dr. Reddy’s Laboratories Ltd ADR (RDY) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $68.77B | $86.12B | $85.45B | $83.79B | $80.33B | $95.00B | $119.48B | $1.42T | $170.22B | $194.76B | $207.65B | $219.82B | $225.60B | $225.43B | $3.07B | $3.63B | $292.83B | $321.85B | $387.52B | $492.99B |
| Cash & equivalents | $3.71B | $18.02B | $7.40B | $5.60B | $6.58B | $5.73B | $18.15B | $51.36B | $33.53B | $39.65B | $39.95B | $18.14B | $2.64B | $2.23B | $27.14M | $202.82M | $14.85B | $5.78B | $7.11B | $14.65B |
| Current assets | $15.42B | $37.56B | $34.62B | $39.01B | $42.06B | $47.59B | $69.95B | $857.13B | $103.75B | $119.84B | $119.69B | $100.38B | $109.64B | $114.50B | $1.72B | $2.03B | $181.86B | $204.25B | $248.05B | $250.11B |
| Total liabilities | $46.50B | $44.44B | $38.38B | $41.75B | $37.41B | $49.02B | $62.03B | $692.64B | $79.42B | $83.46B | $79.31B | $95.78B | $99.14B | $85.23B | $1.02B | $1.26B | $102.30B | $90.86B | $106.97B | $155.82B |
| Current liabilities | $18.74B | $18.58B | $19.39B | $26.55B | $29.02B | $41.02B | $43.46B | $536.46B | $54.06B | $63.99B | $64.65B | $85.00B | $69.69B | $59.70B | $962.50M | $1.14B | $94.02B | $85.84B | $96.04B | $130.39B |
| Long-term debt | $470.71M | $414.64M | $321.44M | $199.17M | $119.80M | $118.34M | $320.99M | $231.57M | $345.67M | $15.00 | $9.94B | $4.85B | $24.46B | $21.45B | $0.00 | $6.30B | $5.75B | $0.00 | $3.80B | $3.80B |
| Shareholder equity | $500.71M | $41.68B | $47.07B | $42.05B | $42.91B | $45.99B | $57.44B | $730.85B | $90.80B | $111.30B | $128.34B | $124.04B | $126.46B | $140.20B | $2.05B | $2.37B | $190.53B | $230.99B | $280.55B | $333.39B |
| Retained earnings | $261.50M | $20.14B | $24.03B | $18.30B | $18.04B | $20.39B | $31.60B | $44.81B | $65.05B | $83.64B | $99.55B | $108.22B | $113.86B | $128.65B | $1.91B | $2.13B | $175.71B | $215.59B | $265.26B | $315.79B |
| Accounts receivable | $4.80B | $7.68B | $6.90B | $19.66B | $15.79B | $22.44B | $30.04B | $38.55B | $41.02B | $48.59B | $48.60B | $45.74B | $50.20B | $46.63B | $816.30M | $843.66M | $80.27B | $83.20B | $95.34B | $109.79B |
| Inventory | $6.89B | $7.56B | $11.13B | $13.23B | $13.37B | $16.06B | $19.35B | $216.00B | $23.99B | $25.53B | $25.58B | $28.53B | $29.09B | $33.58B | $463.52M | $621.11M | $50.88B | $48.67B | $63.55B | $71.08B |
| Goodwill | $16.63B | $15.58B | $16.98B | $7.30B | $2.17B | $2.18B | $2.21B | $31.93B | $3.43B | $3.38B | $3.85B | $3.75B | $3.94B | $3.90B | $52.79M | $62.48M | $4.42B | $4.25B | $4.25B | $11.81B |